-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

When to Use Stem Cell Transplantation for Classical Hodgkin Lymphoma

Program: Education Program
Session: Moving the Needle in Hodgkin Lymphoma
Hematology Disease Topics & Pathways:
Hodgkin lymphoma, Lymphomas, Diseases, Treatment Considerations, Lymphoid Malignancies
Saturday, December 7, 2024, 9:30 AM-10:45 AM

Miguel Angel Perales, MD

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Perales: Sellas: Other: DSMB member; AbbVie: Honoraria; Miltenyi Biotec: Consultancy, Honoraria, Research Funding; Merck: Consultancy, Research Funding; Novartis: Consultancy, Honoraria, Research Funding; Vor Biopharma: Consultancy; Cidara Therapeutics: Other: DSMB member; Allogene: Consultancy, Research Funding; Allovir: Consultancy; Adicet: Consultancy; Sanofi: Consultancy; Nektar Therapeutics: Consultancy, Honoraria, Research Funding; Omeros: Consultancy, Current equity holder in publicly-traded company; OrcaBio: Consultancy, Current holder of stock options in a privately-held company; Incyte: Consultancy, Honoraria, Research Funding; Bristol-Myers Squibb: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Caribou Biosciences: Consultancy; VectivBio AG: Consultancy, Research Funding; Syncopation: Consultancy; Kite/Gilead: Consultancy, Honoraria, Research Funding; Astellas: Honoraria; Karyopharm: Honoraria; MorphoSys: Honoraria; Takeda: Honoraria; Medigene: Other: DSMB member; Servier: Other: DSMB member.

See more of: Moving the Needle in Hodgkin Lymphoma
See more of: Education Program
<< Previous Presentation | Next Presentation